Skip to main content Skip to footer site map

Multiple Myeloma

What should your next step be once you hear the words Multiple Myeloma and try to make sense of them? Call Nebraska Medicine. We are here for you.

Nebraska Medicine is known nationally for being a leading multiple myeloma treatment center, specializing in state of the art chemotherapy and immunotherapy, blood and marrow transplants and surgical options for comprehensive multiple myeloma treatment. Since performing its first bone marrow transplant in 1983, Nebraska Medicine and its academic partner, the University of Nebraska Medical Center (UNMC), have performed more than 5,000 bone marrow transplants.

At Nebraska Medicine, you will benefit from:

Multidisciplinary team approach

A multidisciplinary team of multiple myeloma experts and other specialists work collaboratively to develop a comprehensive and individualized treatment plan for each patient. This includes our multiple myeloma specialists, bone marrow transplant specialists, radiation oncologists, and pain management experts. Our team also works closely with your primary care physician and other providers. The treatment options for multiple myeloma are changing rapidly, including four new drugs in 2015, and our specialists have experience with these new therapies and are up-to-date with the rapidly changing guidelines. We also offer a multiple myeloma clinical trial portfolio which includes trials for newly diagnosed patients, for patients undergoing bone marrow transplant, and for patients with relapsed/refractory disease. This clinical trial portfolio offers new treatment approaches including novel drugs and cellular therapies, and positions Nebraska Medicine at the forefront of myeloma research.

Experts in the field

Our team of multiple myeloma experts include Sarah Holstein, MD, PhD and Muhamed Baljevic, MD. Dr. Holstein has previously served as a myeloma specialist at the University of Iowa and Roswell Park Cancer Institute. She is a member of the NCCN Multiple Myeloma Panel and the Alliance Multiple Myeloma Committee. Her basic science and clinical research focuses on the development of new drugs for multiple myeloma. Dr. Baljivec received his hematology/oncology fellowship training at MD Anderson. His clinical research is focused on understanding and overcoming myeloma resistance to proteasome inhibitors. The bone marrow transplant team members include Julie Vose, M.D., chief of the UNMC Division of Hematology/Oncology and the Neumann M. and Mildred E. Harris Professor and Matthew Lunning, DO, hematologist/oncologist.

We help write the guidelines

Not only is Nebraska Medicine a leader in multiple myeloma, but our doctors are constantly evaluating and updating the guidelines for myeloma care and treatment. Nebraska Medicine is a National Cancer Institute (NCI) Designated Clinical Cancer Center, one of just 20 NCI Designated Cancer Centers in the country. This an alliance of some of the country’s leading cancer centers that collaborate to produce standard evidence-based guidelines for cancer treatment.

Pioneering new treatments

Nebraska Medicine's myeloma program is extremely active in clinical research and clinical trials, providing you with access to the most up-to-date and revolutionary treatments. We are a primary member of the Alliance for Clinical Trials in Oncology, an NCI sponsored cooperative group and a core center for the Bone Marrow Transplant Clinical Trials Network (BMT/CTN).

Nebraska Medicine is also part of the National Institutes of Health/National Cancer Institute Bone Marrow Transplant Clinical Trials Network – a consortium of approximately 20 transplant centers across the country that collaborate on clinical trials in order to derive data from a larger population of patients and to allow for greater sharing of information between centers. Through this network, doctors can study and refine their techniques to diagnose, treat and follow patients, providing them with the most optimal care.

Addressing your personal care needs

Addressing your physical, educational, emotional and spiritual needs are important aspects of providing a more complete and holistic approach to care. A host of amenities and supportive services are available to help meet these needs. This includes physical rehabilitation, yoga and exercise classes, massage therapy, physiotherapy, education and art classes. Personal care services such as wig fittings, cranial and breast prosthetic fittings, as well as skin care products specifically geared for people with or recovering from cancer are also provided in a private setting.

Cancer survivor program

You may also participate in a survivorship program designed to help you deal with the emotional and physical challenges cancer can leave its victims long after treatment has ended.

Highly ranked care.

Nebraska Medicine is ranked among the nation’s best. Each year, U.S. News and World Report surveys the nation’s roughly 5,000 hospitals to come up with the year’s list of Best Hospitals. Just 3 percent of the hospitals analyzed for Best Hospitals earn national ranking in even one specialty.

  • Recognized as a high-performing hospital in cancer in the 2011 U.S. News & World Report Best Hospitals ranking.
  • Ranked nationally cancer in the 2012 U.S. News & World Report Best Hospitals ranking.
  • Ranked nationally in cancer in the 2013 U.S. News & World Report Best Hospitals ranking.
  • Ranked nationally in cancer in the 2014 U.S. News & World Report Best Hospitals ranking.

According to Newsweek’s list of “Top Cancer Doctors 2015,” 75 percent of the top cancer doctors in the state are at Nebraska Medicine.

Accreditations and recognitions.

National Comprehensive Cancer Network (NCCN)
National Cancer Institute (NCI)
Foundation for the Accreditation of Cellular Therapy (FACT)
Magnet status awarded by the American Nurses Credentialing Center (ANCC)
Oncology certified nurses
Blue Cross and Blue Shield of Nebraska, Blue Distinction Center for Complex and Rare Cancers

MENU

Make an Appointment

Call: 800.922.0000

Publications

Connect